[PDF][PDF] Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients

G Lanza, R Gafą, A Santini, I Maestri… - Journal of Clinical …, 2006 - iris.unife.it
G Lanza, R Gafą, A Santini, I Maestri, L Guerzoni, L Cavazzini
Journal of Clinical Oncology, 2006iris.unife.it
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage
II and III Colorectal Cancer Patients Page 1 Immunohistochemical Test for MLH1 and MSH2
Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients Giovanni
Lanza, Roberta Gafa`, Alessandra Santini, Iva Maestri, Laura Guerzoni, and Luigi Cavazzini A
B S T R A C T Purpose To evaluate the prognostic significance of DNA mismatch repair (MMR)
status in a large series of stage II and III colorectal cancer patients. The relationship among …
Purpose
To evaluate the prognostic significance of DNA mismatch repair (MMR) status in a large series of stage II and III colorectal cancer patients. The relationship among MMR status, adjuvant chemotherapy, and clinical outcome was also investigated.
iris.unife.it